Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Evaluation of Outcomes following Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with High-Risk Acute Myeloid Leukemia:

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Investigateur principal

Akshay Sharma (Memphis, US)

Long-term survival after autologous or allogeneic transplantation for T-cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Outcomes of Autologous and Allogeneic Stem Cell Transplantation in Patients with Hepatosplenic T-cell Lymphoma (HSTCL)

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Imke E. Karsten

Allogeneic Hematopoietic Cell Transplantation and CAR-T therapy for T-cell/histiocyte-rich Large B-cell Lymphoma (THRLBCL) A Retrospective Study of the EBMT Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Simon Renders, MD

Trends in Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma. A Retrospective Analysis of the Lymphoma WP of the EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Norbert Schmitz, Anna Sureda

Efficacy and toxicity of CAR T cell therapy in patients with primary and secondary central nervous system lymphoma

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Anna Ossami Saidy

Post-transplantation cyclophosphamide-based after HLA-matched versus haploidentical donor transplants in patients with Hodgkin lymphoma: a comparative study of the LWP EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Dr. Juan Montoro

Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Long term outcomes and relative mortality in survivors of allogeneic hematopoietic cell transplantation in acute myeloid leukemia: an analysis from the ALWP of the EBMT

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Outcome of haploidentical transplant in chronic granulomatous disease

Études rétrospectives

Troubles héréditaires

Inborn Errors Working Party (IEWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Benedicte Neven

Prospective study on the incidence and outcome of HHV-6 encephalitis in patients who undergo allogeneic haploidentical HSCT

Études prospectives non interventionnelles

Complications : infectieuses

Infectious Diseases Working Party (IDWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Katia Perruccio

Allo-HCT in CLL after multiple pathway inhibitors.

Études rétrospectives

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Michel van Gelder/Olivier Tournilhac